Lauren T Reiman

5PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2025
Ribosome Profiling Reveals Translational Reprogramming via mTOR Activation in Omacetaxine-Resistant Multiple Myeloma.

Zachary J Walker, Katherine F Vaeth, Amber Baldwin

|May 09, 2024
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance.

Lorraine N Davis, Zachary J Walker, Lauren T Reiman

|Feb 29, 2024
Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies.

Alana L Keller, Lauren T Reiman, Olivia Perez de Acha

|Oct 10, 2023
CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma.

Xiaocheng Chen, Oi Kwan Wong, Lauren Reiman

|Aug 30, 2023
CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies.

Olivia Perez de Acha, Lauren Reiman, David S Jayabalan

Pageof 1

Frequent Collaborators

5 joint publications

Daniel W Sherbenou

2 joint publications

Sarah E Parzych

2 joint publications

Peter A Forsberg

2 joint publications

Brett M Stevens